We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+27.13%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$329M
AUM Growth
+$97.7M
Cap. Flow
+$49.2M
Cap. Flow %
14.96%
Top 10 Hldgs %
74.44%
Holding
53
New
6
Increased
33
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
CXRX
Concordia International Corp. Common Stock
CXRX
+$40.3M
2
QLTI
QLT Inc
QLTI
+$6.07M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$5.3M
4
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
+$3.1M
5
BSTC
BioSpecifics Technologies Corp.
BSTC
+$2.62M

Top Sells

Rank Stock Value
1
LCI
Lannett Company, Inc.
LCI
+$5.63M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$4.23M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$3.82M
4
TSLA icon
Tesla
TSLA
+$2.83M
5
AKRX
Akorn Inc
AKRX
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 76.88%
2 Technology 7.51%
3 Financials 5.1%
4 Consumer Discretionary 3.81%
5 Communication Services 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.9B
$2M 0.61%
4,950
-3,154
-39% -$1.27M
LCI
27
DELISTED
Lannett Company, Inc.
LCI
$1.89M 0.58%
7,961
-23,479
-75% -$5.63M
META icon
28
Meta Platforms (Facebook)
META
$1.5T
$1.85M 0.56%
21,535
+1,535
+8% +$125K
ENDP
29
DELISTED
Endo International plc
ENDP
$1.82M 0.55%
22,885
+800
+4% +$69.1K
SHPG
30
DELISTED
Shire pic
SHPG
$1.56M 0.47%
6,442
+249
+4% +$61.8K
CBM
31
DELISTED
Cambrex Corporation
CBM
$1.55M 0.47%
35,245
+15,722
+81% +$651K
AMZN icon
32
Amazon
AMZN
$2.47T
$1.41M 0.43%
64,940
+3,120
+5% +$65.2K
VNDA icon
33
Vanda Pharmaceuticals
VNDA
$299M
$1.25M 0.38%
98,775
+28,695
+41% +$309K
AKRX
34
DELISTED
Akorn Inc
AKRX
$1.16M 0.35%
26,506
-48,100
-64% -$2.22M
VTRS icon
35
Viatris
VTRS
$20.8B
$1.02M 0.31%
+15,099
New +$1.07M
TLGT
36
DELISTED
Teligent, Inc
TLGT
$936K 0.28%
14,863
+1,466
+11% +$99.2K
SHAK icon
37
Shake Shack
SHAK
$2.55B
$869K 0.26%
14,414
+9,286
+181% +$634K
TVTX icon
38
Travere Therapeutics
TVTX
$5.27B
$793K 0.24%
23,924
+6,478
+37% +$177K
SBUX icon
39
Starbucks
SBUX
$118B
$673K 0.2%
12,560
+304
+2% +$15.4K
PTX
40
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$602K 0.18%
10,167
– –
STRR
41
DELISTED
Star Equity Holdings
STRR
$479K 0.15%
2,205
+5
+0.2% +$1.04K
FRSH
42
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$425K 0.13%
20,529
+529
+3% +$9.72K
ATRS
43
DELISTED
Antares Pharma, Inc.
ATRS
$296K 0.09%
142,198
+100,150
+238% +$243K
SRPT icon
44
Sarepta Therapeutics
SRPT
$1.65B
$240K 0.07%
+7,899
New +$162K
BDSI
45
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$239K 0.07%
+30,000
New +$258K
GERN icon
46
Geron
GERN
$917M
$128K 0.04%
30,000
– –
CCLD icon
47
CareCloud
CCLD
$104M
$120K 0.04%
63,771
+23
+0% +$46
CTIC
48
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$102K 0.03%
5,227
– –
BB icon
49
BlackBerry
BB
$4.62B
– –
-20,513
Closed -$183K
BKNG icon
50
Booking.com
BKNG
$156B
– –
-9,625
Closed -$448K
1
2
3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, JW Asset Management held 53 positions worth $329M, up 42% from $231M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

JW Asset Management deployed $49.2M of net new capital in Q2 2015, opening 6 new positions and adding to 33 existing holdings. Its largest new stake was Concordia International Corp. Common Stock: 557,500 shares worth $40.2M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 70% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lannett Company, Inc., an estimated $5.63M trimmed.

  • JW Asset Management's largest Q2 2015 buy was Concordia International Corp. Common Stock: 557,500 shares worth $40.2M.
  • JW Asset Management added most to QLT Inc in Q2 2015, an estimated $6.07M increase.
  • JW Asset Management's biggest Q2 2015 reduction was Lannett Company, Inc., cutting an estimated $5.63M.
  • JW Asset Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $3.82M.
  • JW Asset Management's ten largest holdings make up 74% of its $329M portfolio in Q2 2015.
  • JW Asset Management opened 6 new positions and closed 5 in Q2 2015.
  • JW Asset Management's portfolio value rose 42% quarter-over-quarter to $329M.

Based on JW Asset Management's 13F filing for Q2 2015, filed 10 Aug 2015.